Salveen Richter
Stock Analyst at Goldman Sachs
(3.02)
# 1,432
Out of 4,981 analysts
195
Total ratings
40.54%
Success rate
1.78%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintains: Sell | $40 → $45 | $64.04 | -29.73% | 4 | Sep 3, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $7.07 | +437.48% | 5 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $17.91 | +6.09% | 6 | Aug 7, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Sell | $15 → $17 | $24.20 | -29.75% | 9 | Aug 7, 2025 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $37 | $19.94 | +85.56% | 1 | Jun 16, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $55.89 | -15.91% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $11.50 | +13.04% | 3 | May 8, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $55.91 | +86.01% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $18.60 | +120.43% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $8.02 | +12.22% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $13.49 | -25.87% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $568.20 | +41.50% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $148.84 | +32.36% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $25.40 | +25.98% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $4.12 | +336.89% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $117.86 | -18.55% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $25.39 | +100.87% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $14.82 | +169.91% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $11.42 | +5.08% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $16.94 | +18.06% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $86.17 | -18.77% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $468.58 | -21.04% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $31.23 | +143.36% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $36.50 | +45.21% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $282.73 | +23.79% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $397.37 | +40.67% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $22.67 | -77.94% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.17 | +2,549.57% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $324.52 | -30.67% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $4.08 | +439.22% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.34 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.98 | +502.41% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.85 | +85.57% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $3.24 | -7.41% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.40 | +76.47% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $63.93 | -32.74% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $2.98 | -32.89% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $12.22 | +718.33% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $6.97 | +8,508.32% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $101.76 | -50.86% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $29.72 | +51.41% | 1 | Mar 17, 2020 |
Ionis Pharmaceuticals
Sep 3, 2025
Maintains: Sell
Price Target: $40 → $45
Current: $64.04
Upside: -29.73%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $7.07
Upside: +437.48%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $17.91
Upside: +6.09%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $24.20
Upside: -29.75%
Enliven Therapeutics
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $19.94
Upside: +85.56%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $55.89
Upside: -15.91%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $11.50
Upside: +13.04%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $55.91
Upside: +86.01%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $18.60
Upside: +120.43%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $8.02
Upside: +12.22%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $13.49
Upside: -25.87%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $568.20
Upside: +41.50%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $148.84
Upside: +32.36%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $25.40
Upside: +25.98%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $4.12
Upside: +336.89%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $117.86
Upside: -18.55%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $25.39
Upside: +100.87%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.82
Upside: +169.91%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $11.42
Upside: +5.08%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $16.94
Upside: +18.06%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $86.17
Upside: -18.77%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $468.58
Upside: -21.04%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $31.23
Upside: +143.36%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $36.50
Upside: +45.21%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $282.73
Upside: +23.79%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $397.37
Upside: +40.67%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $22.67
Upside: -77.94%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.17
Upside: +2,549.57%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $324.52
Upside: -30.67%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $4.08
Upside: +439.22%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $13.34
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.98
Upside: +502.41%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.85
Upside: +85.57%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $3.24
Upside: -7.41%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.40
Upside: +76.47%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $63.93
Upside: -32.74%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $2.98
Upside: -32.89%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $12.22
Upside: +718.33%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $6.97
Upside: +8,508.32%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $101.76
Upside: -50.86%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $29.72
Upside: +51.41%